Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration

NCT01782989 is registered in ClinicalTrials.gov with Paul Yates, MD, PhD as lead sponsor.

NCT NCT01782989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01782989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Lead sponsor
Paul Yates, MD, PhD
Phase
Phase 2/3
Overall status
Completed
Start date
February 28, 2013
Completion date
November 30, 2020
Enrollment
286 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

geographic atrophy